CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older
Abstract
Authors
J. Zurovac M. Barna M. Georgieva T. Lu M.A.. Marks D. Esposito Laurent S. St. A.M.. Rosen H. Kopel de Velde N. Van E. Beck